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Abstract
We present selected highlights from research that appeared during 2015 on
Tourette syndrome and other tic disorders. Topics include phenomenology,
comorbidities, developmental course, genetics, animal models, neuroimaging,
electrophysiology, pharmacology, and treatment. We briefly summarize articles
whose results we believe may lead to new treatments, additional research or
modifications in current models of TS.
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Introduction
This article is the second in the TS Research Highlights series1.
These articles are meant to disseminate recent scientific progress
on Gilles de la Tourette Syndrome (TS). During each year, the article will be a work in progress, maintained as a web page on the
Authorea online authoring platform (the working draft for 2016
appears here). After the calendar year ends, the article is finalized and submitted as the annual update for the Tics channel on
F1000Research2.

Methods
We searched PubMed on 22 Jan 2016 using the search strategy:
(“Tic Disorders”[MeSH] OR Tourette NOT Tourette[AU]) AND
2015[PDAT]. This search returned 202 citations and includes articles appearing online in 2015 but not officially published by year
end (from journals that still focus on the paper user interface). We
also reviewed F1000Prime recommendations and presentations
of interest at selected medical conferences. Articles were chosen
based on a purely subjective assessment of interest, guided by our
judgment of possible future impact on the field.

Results
Phenomenology and natural history
Tic suppression. Since tic suppression is part of the treatment
protocol for the Comprehensive Behavioral Intervention for Tics
(CBIT) and for Exposure and Response Prevention, there has been
increased interest in investigating the characteristics of tic suppression and the factors that affect it. A study of 26 TS adolescents
compared free ticcing with a tic suppression condition3. During
the free ticcing condition, tic distribution across body locations
was consistent with the view that most tics occur at the level of
the shoulders and above: eye tics were the most frequent, followed
by facial/cervical tics, and those involving the arms and legs. Tics
involving the trunk were the least common. During the tic suppression condition, eye tics increased in 10 subjects, as did hand tics
in 3 subjects. Tic suppression was most successful for tics in body
locations generally associated with fewer tics, such as the legs and
trunk. The authors suggest that tic suppression involves specific,
rather than global, inhibition since some types of tics were easier
to suppress than others. Historically, other categories have been
used to classify tics, such as simple vs. complex tics and motor vs.
phonic tics. The results of this study suggest that future research
may benefit from including body location in tic analyses.
By definition, children with Tourette syndrome (TS) have had tics
for over a year. They can often suppress their tics briefly and they
do so more effectively when rewarded for successful suppression.
It has not been known whether the ability to suppress tics develops
only with practice over the years of having tics or whether the ability
to suppress tics is present when tics initially occur. Greene and colleagues addressed this question in children whose tics had developed
within the past few months4. When children received tokens with
monetary value for tic-free intervals, they had significantly more
of these intervals compared to a baseline, unrewarded condition.
This result suggests the possibility that behavior therapy for tics may
work, at least for some children, even before TS can be diagnosed.

Another study examined the association between tic suppression
and quality of life. Although most tic patients frequently try to
suppress tics, they find suppressing them uncomfortable and distracting. However, those patients who are more satisfied with their
ability to suppress their tics also report a higher quality of life5.
Sensory phenomena. Premonitory urges are common in TS, are
perceived as triggers for tics, and are as bothersome as the tics
themselves to many people with TS. Premonitory urges have a
sensory component and many TS patients also report sensory
sensitivities. Researchers have been clarifying the nature of
premonitory urges and attempting to determine the underlying
causes of sensory sensitivities.
Scores on the Premonitory Urge for Tics Scale (PUTS) and the
University of São Paulo Sensory Phenomena Scale (USP-SPS)
were significantly correlated with total tic severity, tic complexity and vocal tic scores in youth and adults with TS6. The PUTS
and USP-SPS scores were also correlated with scores on the
Dimensional Yale-Brown Obsessive-Compulsive Scale. This
study provides additional evidence that the association between
premonitory urges and tics is complex and may be influenced by
obsessive-compulsive tendencies.
Another study examined the association between premonitory
urges and interoceptive awareness7. Interoceptive awareness was
measured by how well subjects were able to mentally track their
heartbeats, without being able to take their own pulse, during a
specific period of time. Interoceptive awareness, tic severity, and
obsessive-compulsive symptom severity were used in a multiple
regression to predict PUTS scores. Greater interoceptive awareness and tic severity were significantly associated with higher
PUTS scores while OCD symptom severity was not. The authors
suggest that high interoceptive awareness may lead people to set
a low threshold for perception of their own internal physiological
sensations and therefore cause them to interpret these sensations
as an urge to tic. Interestingly, TS subjects had lower interoceptive
awareness than controls overall, suggesting that this downregulation of interoception might reflect a compensatory process.
Symptoms and comorbidity. Recent research has again
demonstrated the wide prevalence of TS-associated comorbidities
and is a reminder of the need to perform studies with large enough
sample sizes to examine the effects of comorbidities on the
dependent variables of interest.
A retrospective review of 1,000,000 people in the Taiwan National
Health Insurance Research Database examined the association
between epilepsy and TS8. 1,062 children and adolescents with
TS were matched on age and sex with a control group of 3,186
subjects. The TS group had an 18-fold increased risk of epilepsy
compared to the control group; the risk was still elevated 16-fold
after adjusting for comorbidities (i.e., bipolar disorder, depression,
learning difficulties, autism, anxiety disorders, sleep disorders).
The authors acknowledge the possibility that some tics may have
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been mistaken for seizures, given the nature of the data set, but these
data do suggest an important hypothesis for future confirmation.
In a large study of psychiatric comorbidity in TS, approximately
800 families were recruited primarily from TS specialty clinics in
four different countries over a 16-year period9. A total of 1374 participants with TS and 1142 family members unaffected by TS were
included. 86% of the TS participants had at least one psychiatric
comorbidity and 72% had either OCD or ADHD. Mood, anxiety
and disruptive behavior disorders each occurred in approximately
30% of the TS participants. The genetic correlations between TS
and mood were accounted for by ADHD and OCD, while ADHD
alone accounted for the genetic correlations of TS with anxiety and
disruptive behavior disorders.
A study of 400 patients seen at a TS specialty clinic found that
39% had coprolalia and 20% had copropraxia10. When the 222
patients with full comorbidity data were examined, only 13.5%
had “pure” TS (i.e., without comorbidities). None of the “pure”
TS group had coprolalia and none had a family history of
obsessive-compulsive disorder.
Emotional regulation difficulties were described in three studies,
reminding us that for many TS patients, tics are not their most problematic symptoms. Greater irritability was seen in TS adults with
more severe tics and those with comorbid ADHD11. Eddy et al.
found that both male and female TS subjects, compared to controls,
reported more distress during emotionally intense situations and
rated their abilities to take other people’s perspectives lower12. An
experienced clinician who has done research on “rage attacks” in
TS has provided a clinically useful summary of current knowledge
regarding aggressive symptoms in TS, OCD, ADHD and mood
disorders, and described treatment options13. Given that emotional
regulation difficulties are frequently associated with greater tic
severity, improving emotional modulation skills may be an appropriate target of psychological interventions.
More research is also being conducted on personality differences
associated with TS. A small study of 17 male adolescents14 found
that the only significant difference between the TS subjects and 51
age- and gender-matched controls on the Minnesota Multiphasic
Personality Inventory-Adolescent version was that the TS subjects
scored higher on the Obsessiveness Content Scale. In contrast, a
study of 50 TS adults in Germany used a variety of instruments to
measure psychological symptoms and personality traits15. Comorbidities were common (41% OCD, 28% depression, 26% ADHD).
Patients with OCD had more severe tics and there was a trend for
those with ADHD to have more severe tics. Only 29% of the patients
had no pathological personality traits, as measured by the Inventory
of Clinical Personality Accentuations. The demand-anxious trait
was the most common personality trait seen in patients and was
present in 39%, while histrionic personality traits were not found
in any patients. Personality traits in patients with “pure” TS were
comparable to those of the control group. Interestingly, ADHD did
not contribute to increased probability of pathological personality traits. Although quality of life was affected by both personality
traits and comorbidities, personality traits had a larger impact on
quality of life.

Course. More research is being conducted on the developmental
progression of tics and other symptoms in TS. This work may
provide clues that help clarify what factors contribute to the
appearance and disappearance of transient tics and what factors
explain the disappearance or amelioration of tics as children with
TS enter adulthood.
One study examined home videos recorded in the first 6 months
of life from 34 children who were exhibiting autistic behaviors in
their second year of life16. Families reported that development during the first year of life had been normal. Videos of 18 boys were
examined in detail. The primary focus of the study was on autism,
though 11 of the 18 subjects were later diagnosed with TS. The
nearly ubiquitous availability of home baby videos in some cultures
suggests that a similar pseudo-prospective study design could be
used to identify behavioral features predicting later development
of TS.
The clinical characteristics of children who developed TS before
the age of 4 were compared with those whose tics developed at
age 6 or older17. The younger group had a higher rate of speech
dysfluencies (e.g., stuttering) and oppositional defiant disorder.
There was no difference between the two groups in prevalence
of ADHD or obsessive-compulsive symptoms. Interestingly, the
children in the early-onset group were more likely to have mothers with tics. The authors attributed this to mothers with tics being
more likely to recognize tics in their children. The authors also
suggest that prenatal or perinatal maternal environmental factors may contribute to the development of tics. An alternative
explanation may relate to the fact that TS is much less common in
girls than in boys. Consequently, tics in a woman may represent
a higher genetic load, resulting in a more severe form of tics and
an earlier age of onset in her children.
Researchers re-evaluated 75 patients previously seen at a
university-based TS clinic after a mean follow-up of 9 years18.
Reported TS impairment was more likely to decrease over time in
males and increase in females. In adulthood, women were more
likely than men to have an expansion of the number of body regions
exhibiting tics, primarily in the upper extremities. This result suggests
that sex continues to influence TS symptoms beyond adolescence.

Etiology
Genetics. The most important genetics news of the year may have
been the presentation by Huang and colleagues at the Tourette
World Congress in London in June, 2015, reporting on a large
collaborative study of copy number variants (CNVs) in approximately 2,500 TS cases and 3,500 controls19. They first tested some
CNVs previously reported in various neurological and psychiatric illnesses; the most significant confirmation in this sample
was of exonic deletions in NRXN1, a gene previously implicated
in autism and TS20. They also searched for new, large CNVs and
identified a novel TS locus, CNTN6, that was significant at a
whole-genome level by permutation testing. This gene and 4 of
the 32 next most likely candidates this analysis identified are neural adhesion molecules20. CNTN6 is a reasonable candidate for
etiologically contributing to TS: its expression in the brain varies
during development21, knockout mice show motor deficits22, and an
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independent study found a variety of neurological and psychiatric symptoms (including 2 with OCD) in 14 patients identified by
CNTN6 CNVs23. On the other hand, fewer than 1% of TS cases in
this sample had CNVs in CNTN6, so its overall importance in TS
remains to be more fully characterized.
A large collaborative group24 studied AADAC, the gene encoding
arylacetamide deacetylase, in which microdeletions had been identified in a previous, smaller copy number variation study. The authors
provide evidence from several sources supporting the connection
of AADAC and TS, including a significant overall association,
new patients with AADAC deletions, and evidence that AADAC
is expressed in the brain, though most strongly in cerebellum,
hippocampus and olfactory bulb, rather than the basal ganglia.
A collaborative genetic study25 demonstrated an association of
TS with 33 genes related to glycolysis or glutamine metabolism.
None of the individual genes would have survived correction for
multiple testing and the results were consistent with a combined
effect of many genetic variants of small effect. These results suggest a new direction for future genetic, electrophysiological, imaging and pharmacological studies.
Yu et al. reported a genome-wide association study (GWAS) from
1,310 people with OCD, 834 with Tourette syndrome, 579 with both
OCD and a chronic tic disorder, and over 5,500 controls matched
for ancestry26. A significant polygenic component was identified for
OCD without tics, but not for the combined patient group or other
subgroups. Overall, this study is consistent with previous work but
it provided disappointingly few novel results.
An international study examined tic symptoms in the United
States and the Netherlands27. Three factors (complex vocal tics and
obscene behavior, body tics, and head/neck tics) accounted for 49%
of the variance in tic-related symptoms. There was no evidence
of heritability for the second factor, but the h2r was approximately
0.2 for the first and third factors when age and sex were included
as covariates. Heritability for these narrower tic phenotypes is considerably lower than the heritability estimates (up to 0.65) when
comorbid conditions such as OCD and ADHD are included. These
authors conclude that broader tic phenotypes, rather than narrower
pure tic phenotypes, may be more successful at identifying the
genetic mechanisms underlying TS.
Environmental risk factors. Researchers used data from the Avon
Longitudinal Study of Parents and Children to identify maternal
factors that increase the risk of tic disorders in offspring28. The Avon
Longitudinal Study is an ongoing, prospective, pre-birth cohort
study of all children born in Avon, United Kingdom, between April
1, 1991, and December 31, 1992. Maternal questionnaires were
administered throughout pregnancy and mothers also completed
questionnaires about themselves and their children’s development
every 6 months from the child’s birth to the age of 7 and then yearly
thereafter. In the final multivariate model, chronic maternal anxiety,
evident both before and after the child’s birth, was associated with
TS or chronic tic disorder in children. This association may reflect
shared genetic susceptibility or prenatal exposure.

Pathophysiology
Pathological studies. An important study follows up on the autopsy
results from the Vaccarino lab by comparing RNA transcripts from
the basal ganglia of 9 TS and 9 matched control subjects29. The
most strongly associated set of downregulated transcripts involved
striatal interneurons, consistent with the autopsy studies. The
leading set of upregulated transcripts involved immune-related
genes even though none of the TS subjects met proposed diagnostic
criteria for PANDAS or PANS. The results obtained in the present
study using brain tissue did not overlap with those of previous
studies using blood samples. The authors interpret their results as
implicating disrupted basal ganglia interneuron signaling in the
pathophysiology of severe TS.
Animal models. Rodent and monkey tic models have been
developed in order to study tic generation mechanisms more directly
and a number of studies using rodent models were published
in 2015. Removing about half of the cholinergic interneurons
in the dorsolateral striatum produced increased fragmented
grooming behavior in response to repeated unpredictable acoustic
startle stimuli in mice and also increased repetitive sniffing
in response to D-amphetamine challenge30. Ablation in the
dorsomedial striatum did not produce similar deficits. None
of the experimental conditions produced a change in prepulse
inhibition. These results provide partial support for the autopsy
data linking some characteristic TS symptoms to cholinergic
interneuron deficits in the dorsolateral striatum.
A rat model was used to determine to what extent cortical and
striatal input affected the temporal and spatial properties of motor
tics31. Focal blockade of GABA-A receptors with bicuculline injections into the anterior striatal motor region produced focal tic-like
movements of the forelimbs. Medium spiny neurons (MSNs) and
fast spiking interneurons (FSIs) exhibited increased activity during these movements, and all of the MSNs were only active during
them. All of the FSIs were active during tics, but a minority followed this increase in activity by a decrease. Four different patterns
were seen in globus pallidus (GP) neurons. About half of the GP
neurons demonstrated increased activity during the tic-like movements, while the rest showed only inhibition or a combination of
inhibition and excitation. The effects of cortical input were studied using short bursts of high-frequency electrical pulses applied
at random intervals to the region of primary motor cortex representing the forelimb. Stimulation was provided before and after
the bicuculline injections. The results suggested that the precise
timing of tic occurrence was related to both incoming excitatory
cortical input and the delay since the previous tic. These results
support the fundamental involvement of the corticostriatal network
with tic occurrence.
The role of GABA in tic generation was also studied in adult
mice by injecting the GABA-A antagonist picrotoxin into areas
throughout the cortex and striatum32. Infusions into the central and
dorsolateral striatum produced tic-like movements of the front
paw, hind paw or head. Infusions into the dorsomedial striatum did
not have a significant behavioral effect. Infusion into the ventral
striatum produced increased locomotor activation in addition to
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sterotypical sniffing and wall licking without other tic-like movements. Infusions into the sensorimotor cortex produced tic-like
movements in addition to increased behavioral activation involving cage exploration, sniffing, and occasional licking. When an
NMDA receptor antagonist was infused into the dorsolateral striatum prior to infusing picrotoxin into the same location, tic frequency
decreased significantly, thus demonstrating a role of glutamatergic activity in tic generation. Infusion of a GABA-A agonist into
the sensorimotor cortex prior to picrotoxin infusion in the dorsolateral striatum also resulted in significant tic suppression.
EEG recordings ruled out seizure activity. The authors summarize
these results as providing evidence that these tic-like movements
require corticostriatal interactions, with a key role for glutatmateric
afferents, rather than autonomous striatal activity.
In a genetically engineered mouse model of TS+OCD (“Ticcy”
D1CT-7 transgenic mice)33, a small population of dopamine D1
receptor-expressing (D1+) somatosensory cortical and limbic
neurons is chronically potentiated, resulting in cortical and amygdalar glutamatergic excitation of striatothalamic, striatopallidal
and nigrostriatal subcircuits. Tics were decreased by the use of
drugs that acted at different points in this “hyperglutamergic cortico/amygdalo-striato-thalamo-cortical [CSTC] circuit”. Excitatory forebrain serotonin and norepinephrine activity was blocked
by ritanserin (a serotonin 2a/2c antagonist) and prazosin (an
α1 adrenergic antagonist) respectively. In contrast, downstream
striatothalamic neurons’ glutamate-triggered GABA output and
downstream nigrostriatal neurons’ glutamate-triggered co-modulatory dopamine output were blocked by moxonidine (an agmatine/
imidazoline-1 agonist) and bromocriptine (a D2 dopamine agonist) respectively. All four of these drugs decreased tic frequency
and were considered to be “circuit-breakers” for the hyperglutamatergic CSTC circuit, thus supporting an important role of
glutamate in generating the abnormal tic-like movements seen in
these mice.
Neuroimaging studies. The challenges of using neuroimaging
techniques to study pediatric and clinical subjects are described
in detail along with suggestions concerning various strategies that
can be used to collect higher quality data34. The profound effects
of even very small head movements on structural MRI analyses
were identified in a well-designed study35. T1-weighted MRI of
brain was acquired in 12 healthy adults while they were still or
engaged in specific types of movement including nodding, head
shaking or a movement each subject invented and then repeated
during the scan run. Even during scans when subjects attempted
to remain still, there was an average of 3 mm/min of accumulated
motion measured as root mean square displacement per minute.
During the motion conditions, substantial impact was found on
gray matter volume and thickness estimates. Apparent volume
loss averaged approximately 0.7% mm/min of subject motion.
The greatest reductions in gray matter occurred in pre- and postcentral cortex and in the temporal lobes. Motion-associated increases
in thickness were seen in some frontal regions and deep sulci such as
the medial orbital frontal region. Significant effects due to motion
were still present even after excluding scans that failed a rigorous
quality control procedure. Recommendations included reducing
head motion during scans as much as possible, controlling for motion
in statistical analyses, and using correlational analyses to determine

the associations between head motion and the predictors of
interest. Tisdall and colleagues described a method to limit the
effects of movement artifacts by using a motion tracking system
to provide prospective motion correction during scanning36.
A whole-brain analysis of cortical gray matter found reduced gray
matter (GM) thickness in the insula and sensorimotor cortex for
29 TS children and young adults compared to a matched control
group37. GM thickness in these areas correlated negatively with
Premonitory Urge for Tics Scale scores.
Resting-state functional magnetic resonance imaging identified
greater functional connectivity between the right dorsal anterior
insula (dAI) and the bilateral supplementary motor area (SMA)
in TS adults compared to controls38. Post-hoc analyses found
significant correlations between PUTS scores and connectivity
between right dAI and right SMA2 and between right dAI and left
SMA1. These regions may be involved in the increased awareness
of body sensations that tend to be associated with premonitory
urges. The authors paid attention to head movement and removed
high-movement frames. However, recent result suggest that the
motion threshold of 0.4mm used in this analysis, and the choice
not to regress global signal, may not adequately remove artifactual correlations between brain regions due to residual small head
movements during the scan39.
A review summarized TS task-based fMRI studies in TS including studies of tic suppression, voluntary motor execution, voluntary
motor inhibition, and tic severity40. Free ticcing conditions (four
studies) most commonly activated the left cerebellum, right cingulum, left middle frontal gyrus, the Rolandic operculum, right
pallidum, right SMA and thalamus. In motor response inhibition
studies, on No-Go trials TS subjects exhibited greater activation in
the bilateral prefrontal cortex, thalamus and caudate. In contrast,
on voluntary motor execution tasks greater activation in TS subjects was seen in the left prefrontal cortex, right cingulum, and the
anterior SMA. Tic severity ratings were correlated with greater
activation of the right dorsal premotor cortex and the SMA. Anterior cingulate cortex and SMA were involved across task types.
The thalamus was involved in all types of studies except for selfproduced movements. The authors also briefly summarize the many
issues related to neuroimaging tasks, such as associated comorbidities, medication effects, the need for longitudinal studies, and the
confounding effect of tics during scanning. Additional neuroimaging studies of note are noted in Table 1.
Electrophysiology. Local field potentials associated with
spontaneous tics were studied in 3 patients during DBS surgery46.
In all 3 patients repetitive thalamo-cortical coherent activity was
present from 800 to 1500 msec prior to tic-associated muscle
contractions. The frequency range affected varied among the patients
and there were also ongoing intermittent intra-thalamic coherences
that were not synchronized to the tics. The authors speculated that
specific DBS targets may not matter as much as whether the target
is part of the striato-pallido-thalamo-cortical network. However,
since these patients were older and had very severe and complex
tics, the authors acknowledge that it is not yet clear to what extent
these results generalize to the TS population as a whole. Additional
studies are noted in Table 1.
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Table 1. Additional neuroimaging and electrophysiology studies.
Reference

Comment

Motor execution and motor
imagery41

An exploratory study found increased cortical premotor and prefrontal neural activation for both
imagined and performed movements in TS subjects compared to controls. Premotor activation
during the motor imagery task was correlated with tic severity.

Structural MRI in pediatric
TS42

A preliminary report of a multi-site study with over 200 subjects found TS children had greater gray
matter volume in the posterior thalamus, hypothalamus and midbrain in addition to decreased
white matter volume in orbital prefrontal and anterior cingulate cortex.

DTI and the corpus
callosum43

Axial diffusivity (AD) was reduced in treatment-naive boys with “pure TS” compared to controls.
AD was negatively correlated with tic severity, although this result was not significant after
Bonferroni correction.

TS and Chronic Tic
Disorder44

Both TS and chronic tic disorder groups exhibited similar increases in parietal and central eventrelated potentials, adding to evidence that TS and CTD may be the same illness.

Event-related potentials45

Reduced P300 amplitudes in frontal regions were related to TS-associated comorbidities rather than
to TS itself.

Pharmacological studies. GABA involvement was studied in
23 TS children, aged 8–12, and 67 controls using a battery of
vibrotactile tasks with a subset of the children (19 with TS, 25
controls) also undergoing GABA-edited magnetic resonance
spectroscopy (MRS)47. Lower GABA concentration in the right
sensorimotor cortex correlated with greater motor tic severity
(r = –0.55). There were no significant differences between groups
on reaction time and baseline amplitude discrimination threshold.
However, TS children showed impaired tactile adaptation. The
authors suggest that MRS GABA and tactile measures might useful
as biomarkers of treatment response.
Positron emission tomography (PET) was used to investigate
striatal D2/D3 dopamine receptor availability in TS subjects and
controls using a D2/D3 receptor antagonist ([11C]raclopride) and
an agonist with preferential binding to D3Rs ([11C](+)PHNO)48.
No differences were found in striatal regions when the TS subjects were compared with the controls, and there were no significant correlations between receptor availability and tic severity.
The authors concluded that their results challenge the widely held
view that striatal dopamine receptors have a fundamental role in TS
pathophysiology, though they acknowledged that endogenous
dopamine levels may have influenced the results since these radiotracers are displaceable by physiological synaptic concentrations
of dopamine.
Two studies examined dopamine D1 and D2-like receptors in
healthy adults, measuring D1R and D2R availability during stopsignal and continuous performance tasks49. Stop-signal reaction
time was negatively correlated with both D1R and D2R receptor
availability in the the associative and sensory motor regions of the
striatum. In contrast, neither D1R nor D2R receptor availability
was associated with performance on the continuous performance
task, suggesting that stop-signal and continuous performance tasks
are associated with different neurochemical mechanisms related
to motor response inhibition. In a study of healthy adults, learning
from positive outcomes was positively correlated with D1R binding
in the putamen and caudate while there was an inverted U-shaped

relationship (r2 = 0.19) between learning from negative outcomes
and D2R binding in the putamen50. A dietary manipulation that
reduced dopamine precursor levels significantly improved learning
from negative outcomes. These results were interpreted as providing evidence that dopamine acts as a reward prediction error signal
rather than as a saliency signal.
A detailed review focuses on histaminergic modulation of striatal
function and its possible role in TS51. The authors suggest that during wakefulness and increased attention, histaminergic neurons
will be more active with the result that the striatum will be more
responsive to thalamostriatal input and feed-forward inhibition will
dominate. Several lines of evidence related to the role of histamine
in TS were discussed. A family linkage study identified a rare mutation in the gene encoding histidine decarboxylase. HDC transgenic
mice exhibit decreased pre-pulse inhibition of startle responses
and an increase in a variety of amphetamine-induced stereotypies that were prevented by pretreatment with histamine infusion or
use of haloperidol. Reduced histamine production was suggested
to produce dopaminergic disregulation of the basal ganglia and
symptoms similar to those seen in TS.
Clinical and neuropsychological studies. In an intriguing report
from a group studying social cognition, TS subjects exhibited
intact mentalizing when observing animated triangles demonstrating simple and complex interactions52. However, unlike controls,
TS subjects also tended to attribute human-like intentions when two
triangles were moving randomly. This tendency was not explained
by clinical symptoms or by other constructs such as executive
function or alexithymia.
Two studies examined the effects of comorbidities on social and
cognitive skills. Social responsiveness and cognitive flexibility
were examined in TS children and adolescents53. TS subjects
were rated as having poorer social motivation and skills, using the
Social Responsiveness Scale, compared to age-matched controls.
TS subjects also took significantly longer to complete the Trail
Making Tests which measure cognitive flexibility and visual motor
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integration. However, of the 31 TS subjects, 11 had OCD, 18 had
ADHD and 8 had an anxiety disorder. Once these comorbidities
were taken into account, group differences on the Trail Making
Tests and the Social Responsiveness Scale were no longer significant. These findings demonstrate the need for studies to have
adequate sample sizes to provide sufficient power to disentangle
effects related specifically to tics rather than to other symptoms.
Another study was designed to separate effects attributable to
OCD54. Sustained attention, using a continuous performance test,
was examined in 48 children and adolescents who had OCD alone,
tic disorders (TD) alone or both OCD and TD. A high rate of
ADHD was seen in all groups (62% of the OCD+TD group, 27%
in the TD alone group, and 20% in the OCD alone group). Anxiety was also frequent (77% in the OCD+TD group compared to
49% for the other two groups combined). The OCD+ TD group had
more errors of omission and higher reaction time variability. These
results of this study provide additional evidence that the OCD+TD
phenotype is associated with more severe symptoms including
attentional difficulties and symptoms of anxiety.
Two studies examined motor control. In a clever analysis of video
recordings of the eyes55, spontaneous blink rate, which is related
to dopamine levels, was higher in children with TS than in controls both during task performance and during a rest period. In
contrast, pupil diameter, which is related to norepinephrine levels,
was correlated with anxiety in TS subjects although not in controls.
Researchers also used a cognitive control task to measure ability to
properly update current task information, ignore competing information when selecting between response options, and retrieve and
use relevant response contingencies. Accuracy on this cognitive
control task accounted for half of tic severity variance. In an unrelated study, TS children without ADHD or OCD had significantly
greater difficulty maintaining postural stability than did age- and
gender-matched controls, especially when subjects had access only
to accurate vestibular, rather than visual or somatosensory, cues56.
Somatosensory sensitivity was compared in adults with “pure”
TS and controls by establishing thresholds for externally applied
stimuli57. No differences were found between the two groups, supporting the view that the sensory abnormalities seen in TS may be
related to abnormal interoceptive awareness or abnormal central
sensorimotor processing.
Three recent studies examined the effects of attention on tic frequency and the results have implications for how treatment protocols could be modified to increase effectiveness. In one study,
the role of attention on tic frequency was examined under several
conditions58. Tic frequencies were lower for 12 TS subjects during
a baseline condition when they were alone in a room compared to
when they were alone in a room looking at themselves in a mirror.
Researchers then determined whether the increase in frequency was
due to increased attention to the tics themselves or due to increased
self-awareness in general. In addition to the conditions previously
described, 16 subjects were also shown videos of themselves while
they were not ticcing. Tic frequency was again lower during the
baseline compared to the mirror condition. Tic frequency was even
lower when subjects were watching the video of themselves while

not ticcing. The authors suggest that future treatments teach patients
to attend to states when they experience fewer tics. Another study
of TS adults59 compared tic frequency while subjects were engaged
in tasks that involved attending to particular fingers, colored circles,
or whether a tic had occurred during a specific 2-second interval.
Observations for these tasks were made both during free ticcing
and tic suppression. Not surprisingly, more tics were seen during a
baseline free ticcing condition. During the attention tasks, tic frequency was greatest while subjects focused on their tics. In contrast, tic frequency decreased during the color attention condition
and decreased further during the finger attention condition. When
subjects suppressed their tics, they reduced their baseline tic frequency similarly across all attention conditions. These results are
consistent with the idea that internally-directed attention, especially
with a focus on tics, may contribute to momentary increases in tic
severity. The authors suggested that behavioral treatment might be
more effective if it focused on teaching patients to focus on external
events and voluntary actions when they are in situations that are
most likely to result in ticcing. Anecdotal evidence has suggested
that tics decrease when people are involved in musical activity, so
Bodeck et al. systematically studied the effects of music.60 Questionnaires completed by 29 patients supported the idea that listening to music and performing music decrease tic frequency. Eight
TS subjects were then observed in a variety of conditions. Tics
were almost completely eliminated when subjects were performing music. Listening to music and using mental imagery of musical
performance also resulted in decreases in tic frequency. The authors
suggested that focused attention, along with fine motor control and
goal-directed behavior, produced the decrease in tics.
The stereotyped nature of tics has led some to suggest that the neural systems involved in habitual behavior may also be associated
with tic generation. A complex, three-stage instrumental learning
paradigm was used to compare medicated and unmedicated TS
adults with a control group to determine whether they differed in
goal-directed vs. habitual behavior61. During the first stage, subjects
learned to associate six different stimuli with six specific outcome
pictures and a specific response (i.e., left or right key press). During
the second stage, subjects were presented with two outcomes with
an indication that one outcome was devalued (i.e., no longer associated with point rewards) and subjects had to press the key associated
with the outcome that would still generate points. During the third
stage (i.e., “slip-of-action” stage), the six outcomes were presented
simultaneously with indications that two outcomes were devalued
so that responding to the associated stimuli would no longer generate points. Subjects were instructed to press the key associated
with stimuli associated with the still valued outcomes (i.e., “Go”)
and withhold the response (i.e., “No-Go”) for stimuli associated
with devalued outcomes. This task determined whether excessive
“slips of action” were related to outcome devaluation insensitivity. A control Go/No-Go task, which involved devaluation of cueing stimuli, was used to measure to measure response rates where
high rates on this task would indicate working memory deficits or
deficient response inhibition. There were no group performance differences for the first two stages of the instrumental learning task
or on the baseline Go/No-Go task. However, unmedicated patients
showed a significantly higher response rate to devalued outcomes
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compared to controls (in Bonferroni-corrected post hoc analyses),
while there was no difference between medicated subjects and
controls. In addition, tic severity in unmedicated subjects was correlated with response rates to devalued outcomes and with stronger
structural connectivity between the right supplementary motor
cortex and the posterior putamen. The results obtained in this
study contrasted with results on similar tasks obtained with subjects with obsessive-compulsive disorder without tics. The
authors argued that over-reliance on habits in OCD without tics is
associated with impaired knowledge of response-outcome associations, while this type of learning was intact in both TS groups
in this study. They concluded that habit formation is enhanced
in unmedicated TS subjects but medication may normalize
responses.

Treatment
Psychotherapy. 2015 saw several practical advances in the
psychotherapeutic treatments available for tics. TicHelper.com
is a commercial adaptation of Comprehensive Behavioral Intervention for Tics (CBIT) to the Internet, discussed at the London
congress in 2015.62 It is potentially an important treatment
option, especially for the many TS patients who do not live near a
behavior therapist. Efficacy testing is ongoing (see the trial summary at ClinicalTrials.gov).
McGuire et al. dug into the data from 2 previously reported,
pivotal, randomized controlled CBIT studies that together enrolled
over 200 children and adults63. The superior treatment benefit
from CBIT, compared to a control therapy, could be attributed to
differential improvement in only a few types of tics, including throat
clearing, sniffing, and complex tics. In general, vocal tics were
more likely to improve following CBIT treatment. The controlled
breathing used as a competing response for vocal tics may have
allowed patients to direct attention away from the associated premonitory urges in a way that muscle-tensing competing responses
for motor tics did not. This report also extends previous information
about premonitory phenomena, including varying prevalence of
premonitory urges across specific tic types.
“Living with Tics” is a modularized cognitive-behavioral treatment focused on decreasing tic-related impairment and improving quality of life. This treatment program was recently tested in a
randomized, wait-list control study, with the active intervention
including up to 10 weekly sessions for children and adolescents64.
Treatment modules focused on a variety of themes including selfesteem, emotion regulation, parent training, cognitive restructuring, coping at school, overcoming tic-related avoidance, and 1 or
2 sessions of habit-reversal training. Active treatment led to
improved child-rated quality of life and reduced blinded clinicianrated tic impairment compared to the wait-list control group. An
additional 7 wait-listed youth then participated in the treatment
program resulting in data on 19 participants for open-trial analyses.
With the larger sample size the reductions in tic severity (i.e., 30%),
anxiety, obsessive-compulsive symptoms, and parent-rated impairment were significant. Both the youth and their parents reported
satisfaction with the intervention, serving as a reminder that
improving quality of life can be a desired treatment goal.

A small, uncontrolled open trial of mindfulness-based stress reduction treatment involved 18 individuals who were at least 16 years
old.65 Treatment consisted of eight weekly two-hour group classes
and one four-hour retreat. Participants were taught a tic-specific
meditation exercise that involved noticing any urges to tic while
maintaining a focus on one’s breathing rather than trying to change
or eliminate the urge to tic. Only one subject dropped out and
overall tic severity was decreased by 20% for participants who
completed the program. An independent evaluator rated ten subjects
as “much improved” or “very much improved” and these subjects
were considered treatment responders. The gains for the fifteen
participants who had not had medication changes in the interim
were maintained at a one month follow-up visit.
An unblinded trial of psychotherapy using a cognitive psychophysiological model of tic behavior was conducted with 102 adults who
had TS or chronic tic disorder66. Ten weeks of individual psychotherapy involved a number of components including increasing tic
awareness; improving muscle control; preventing excessive muscle
tension; decreasing an overactive action style; identifying low and
high risk activities in terms of tic probability; highlighting differences in behaviors, thoughts and feelings related to differences in
tic probability; decreasing perfectionistic beliefs linked to tension;
generalization; and relapse prevention. These psychotherapy components were chosen because prior research suggested that some
people with tics have perfectionist beliefs leading to an “impulsive
overactive style” that produces frustration and tension in addition to
tics. Large effect sizes were seen for both patient groups compared
to the waiting list control group: 65% of the chronic tic disorder
group and 74% of the TS group had reductions of more than 35%
on the Tourette Syndrome Global Scale (TSGS). YGTSS total tic
scores were also significantly decreased for both patient groups. At
the end of treatment 78 of 85 completers were rated as having no
more than mild symptoms, regardless of the starting severity, while
the other 7 were considered to have moderate symptoms. Large
effect sizes were seen for tic subtypes (i.e., simple, complex, motor,
phonic) and similar results were seen across tic body locations. The
TSGS improvements were maintained in the 52 subjects who completed a 6-month follow-up evaluation.
A study by the same group examined the effects of this psychotherapy approach on event-related potentials and lateralized readiness
potentials (LRPs)67. EEGs were recorded for 20 TS subjects and 20
control subjects matched for age, sex and intelligence while performing a stimulus-response compatibility inhibition task. During
the No-Go condition, the TS group exhibited a delayed and overactivated frontal late positive component on the No-Go portion of
the task. The authors considered this frontal activation as evidence
of an adaptive mechanism that allowed patients to perform similarly to the control subjects on the task. This difference did not normalize with psychotherapy, consistent with this interpretation. TS
subjects exhibited a larger incorrect activation of the stimuluslocked LRP (sLRP) in addition to larger correct activation of the
sLRP and delayed correct activation sLRP onset. Although sLRP
onset and response-locked LRP (rLRP) peak normalized after
psychotherapy, the larger sLRP amplitude did not. The authors
suggested that therapy produced some normalization of activation
in the premotor and motor cortex.
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Medication. Efforts to maximize the value of pharmacological
treatment continue. Lemmon et al. reported on a carefully
designed, thoughtful pilot study of glutamatergic modulators as tic
treatment68. Twenty-three children with TS completed a doubleblind, parallel group study involving 6 weeks of placebo, D-serine
(up to 30 mg/kg/day) or riluzole (up to 200 mg/day). YGTSS total
tic scores improved by 25–38% in each group, without significant
group differences. Although power was limited by the small sample
size, this null result argues against eager pursuit of glutamatergic
medications for TS at this juncture.
A meta-analysis of 22 randomized, controlled trials (RCTs) involving 2,385 children with ADHD found no causal relationship
between stimulants and onset of tics69. Rather, tics were associated
with ADHD itself (5.7% in the psychostimulant groups and 6.5% in
the placebo groups). This summary of previous evidence hopefully
can further reassure patients and prescribers that stimulants do not
cause tics. The evidence for this conclusion is strongest for methylphenidate (19 of the 22 trials), and in a large RCT in children with
TS and ADHD, tics improved significantly with methylphenidate70.
In the meta-analysis, results were similar for the 3 trials involving
amphetamines, but tic severity did increase in 12 adults with TS
after a single intravenous dose of 0.3mg/kg D-amphetamine71.
Four patients with treatment-refractory TS were studied in an early
report of results using vigabatrin, a medication from the GABAaminotransferase inhibitor class72. One patient had a clinically
significant reduction in tics while two others had tic reduction of
approximately 25% but did not report subjective clinical improvement. Further study will be needed.
Neurosurgery. A revised consensus statement on the use of DBS
in TS appeared recently73. It provides an important update to the
2006 recommendations74, guided by almost a decade of generally
positive results from an increasingly varied set of patients, though
with limited evidence from randomized allocation treatment
studies. Several major changes were made in the recommendations.
First, the recommendation that DBS patients be 25 years or older
has been replaced by a focus on clinical symptoms and severity.
However, at a minimum, local ethics committee involvement was
recommended for patients under 18 years of age. The second major
modification in the guidelines was that a patient have a caregiver
who would be available to accompany the patient to frequent
follow-up appointments. In addition, the group recommended
absence of active suicidal or homicidal ideation for 6 months
prior to surgery. The final change in the guidelines recommended
identifying and addressing personality disorders, malingering,
factitious symptoms, embellishment, and other factors that can
substantially complicate assessment and treatment.
Treatment effectiveness was examined by randomly allocated
to DBS on-stimulation or off-stimulation conditions for the first
3 months after DBS leads were placed in the GPi (globus pallidus,
pars interna). Patients were then switched to the other condition
for another 3 months75. Ratings were collected blind to stimulation
status, and 13 patients completed assessments during both conditions.

Total YGTSS scores were 15% lower at the end of the on-stimulation period compared with the off-stimulation period (p=0.048).
Three serious adverse events occurred: two infections in the DBS
hardware and one episode of hypomania. Further improvements
were seen during the long-term open label treatment period. This
study is important as it provides evidence of efficacy of stimulation
per se from a study with random assignment to initial condition.
A case study raised the issue of temporary DBS treatment in a
patient with TS and ADHD treated with thalamic DBS from age
of 17 to 2376. This case highlights the issue of DBS in minors
discussed in the consensus statement73, but without adequate controls it is impossible to know whether DBS was the cause of tic
improvement.
Other treatment. Lisanby and colleagues reported a careful,
randomized controlled trial of repetitive transcranial magnetic
stimulation (rTMS) aimed at the supplementary motor area (SMA)
in 20 adults with TS77. There were suggestions of improvement, but
on average, patients in the sham treatment group improved almost as
much as those in the active treatment group. However, rTMS most
effectively stimulates superficial regions of cortex, and an Israeli
group employed a new coil designed to provide deeper stimulation
in an open-label study of 12 patients with treatment-refractory
TS78. On average, the 12 patients did not improve significantly, but
the treatment was well tolerated, and a post hoc analysis showed
benefit in the 6 patients who also had OCD. A double blind, shamcontrolled study in TS patients with OCD will be needed to confirm
efficacy.
Cranial electrical stimulation (CES) was used in an open label trial
to treat 42 children with TS who were less than 12 years old79.
Patients applied electrodes to their earlobes when they went to bed
so that they could receive the treatment on a daily basis for 24 weeks.
Treatment sessions lasted 60 minutes and children were allowed to
sleep during treatment. Only one child dropped out before completing the study. The mean YGTSS score significantly decreased
from 26 when they were initially seen to 11 after treatment completion. These results must be viewed as preliminary, since an RCT is
required to rule out spontaneous improvement.
Another treatment undergoing initial efficacy testing is an oral
orthotic device with which some patients have reported success.
The rationale and design of the study, and initial safety results, were
reported at the London meeting80, and efficacy testing continues
(see the trial summary at ClinicalTrials.gov).

Tics, family and society
Two studies examined the association between parenting a TS
child and parental stress. Using self-report data, Stewart and colleagues revealed that stress in parents of 74 children with Tourette
syndrome was highly correlated with current ADHD symptom
burden in the child (r = .57) and, less strongly, with the child’s OCD
symptoms (r = .40)81. However, perhaps surprising some readers,
parental stress was not significantly correlated with current tic
severity (r = .18, p = .13). The correlation of parental stress with
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ADHD and OCD symptom severity was present to a similar degree
in 48 control children without tics. These observations reinforce the
need for optimal clinical management of TS to include appropriate
treatment of associated comorbidities. In another study 28 parents of 21 TS children completed questionnaires on their anxiety,
depression, and perceived stress82. Eight of the parents reported a
moderate or severe level of anxiety. In general, parents varied in
terms of their self-reports of their coping skills and social support
availability. These results remind clinicians that it is important to
evaluate the social support available to families of TS children, and
suggest that increasing parental coping skills may improve the quality of life in TS families.
Attitudes toward treatment were investigated using a survey of
295 parents of youth with TS and interviews with 42 young people with TS83. These subjects were identified through Tourettes
Action, a non-profit organization in the U.K. Patients tended to
view aripiprazole more positively than other treatments. Three
quarters of parents wanted access to behavior therapy for their
child, but reported substantial trouble finding it. On the other
hand, many young people were skeptical that behavior therapy
would help. Importantly, patients identified several treatment outcomes other than tics per se as important to them: reduction of
premonitory urges, increasing control over tics, and reducing
anxiety.

Additional reference sources
David Shprecher and colleagues recently published a thoughtful, forward-looking, but concise review of Tourette research and
treatment84. Mary Robertson85–88 reviews work that she and colleagues have done during her 35-year career treating TS patients
and her 30 years of publishing TS research. Jankovic provided an
overview of tic treatments89, and one of our colleagues highly recommended a review of current medication treatment practice in
Germany90.
Jackson et al. describe how increased motor control occurs in TS
adolescents along with a variety of compensatory mechanisms91.
These researchers make the case that increased inhibitory capacity within higher-order motor regions, such as the SMA, may alter
motor excitability. Hawksley et al. summarize evidence suggesting
that autonomic dysfunction may have a role in both epilepsy and
Tourette Syndrome92. They also discuss how electrodermal activity
biofeedback reduced seizure activity significantly in patients with
epilepsy. In contrast, TS subjects had difficulty reducing sympathetic activity, suggesting that treatment protocol modifications are
needed for TS.
In December, 2015, a special issue on Tourette Syndrome appeared
in the new journal Current Developmental Disorders Reports.
Four of the 5 articles are clinically focused13,93–95. The other article
summarizes some of the recent advances in TS neuroimaging96.

Abstracts of presentations from the 1st World Congress on Tourette
Syndrome & Tic Disorders, London, 24–26 June 2015, are available
online. The Tourette Association at regular intervals posts links
on its web page to selected scientific articles relevant to TS97.
Finally, the authors are building the 2016 version of this
article here, where readers are invited to submit suggestions or
comments.

Conclusions
TS is a complex condition to study because of the high rate of
comorbidities, the differences in tic severity between people identified through community studies and those who participate in
research studies conducted at tertiary care centers, the differences
in types of tics (e.g., vocal vs. motor tics, simple tics vs. complex tics), childhood onset, and prominent fluctuations in severity
over time. The studies published in 2015 demonstrate continued
progress in addressing some of these obstacles.
Although many early research studies focused on the roles
of dopamine and the basal ganglia in tic generation, more
recent studies are adding to our understanding of the complexity of tic generation and identifying possible roles for glutamate
and histamine, along with a variety of subcortical and cortical
regions. A number of carefully executed, large treatment studies
have been reported, yet none is effective for more than
about half of the patients enrolled, and side effects, cost or availability
limit many existing treatments. Novel treatments are still
needed.
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